Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation

Trial Profile

Phase-II Clinical Trial Evaluating Guanfacine for Smoking Cessation

Recruiting
Phase of Trial: Phase II

Latest Information Update: 27 Jun 2017

At a glance

  • Drugs Guanfacine (Primary)
  • Indications Smoking withdrawal
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 May 2016 Planned End Date changed from 1 Apr 2017 to 1 Apr 2018.
    • 06 May 2016 Planned primary completion date changed from 1 Nov 2016 to 1 Nov 2017.
    • 08 Oct 2015 Planned End Date changed from 1 Apr 2016 to 1 Apr 2017 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top